Evidence map›Paper›PMID 40910631›Full record

ReviewClinical microbiology reviews2025

Dengue and severe dengue.

Shirin Kalimuddin, Po Ying Chia, Jenny G Low, Eng Eong Ooi

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Zika immune imprint risks dengue.Nature immunology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Dengue and Acute Pancreatitis: A Systematic Review.Tropical medicine and infectious disease · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shirin Kalimuddin *Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0001-9319-5908
Po Ying Chia *National Center for Infectious Diseases, Singapore, Singapore.ORCID 0000-0002-8797-9527
Jenny G LowDepartment of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
Eng Eong OoiProgram in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0002-0520-1544

Funding

National Medical Research Council MOH-000617-00National Medical Research Council MOH-001271-00
6 · The paper itself

Abstract

SUMMARYDengue is an acute mosquito-borne viral disease that is highly prevalent throughout the tropical world. The geographic footprint of the four dengue viruses (DENV-1 to -4) that cause this disease and their

Indexed as

DengueDengue VirusSevere DengueAnimalsAntiviral AgentsDengue VaccinesHumansAntiviral AgentsDengue Vaccinesadult denguedenguedengue virus (DENV)host factorshost responseimmunitytherapeuticsvaccines

Identifiers

PMID40910631
PMCPMC12697202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.